Why Lantheus Holdings Is Dropping Today

Shares of Lantheus Holdings (NASDAQ: LNTH), a company focused on diagnostic medical imaging equipment and supplies, dropped 21% as of 10:35 a.m. EDT on Wednesday after the company announced that it is acquiring Progenics Pharmaceuticals (NASDAQ: PGNX), a commercial-stage biotechnology company focused on cancer.

Here are the key terms of the deal:

Traders don't appear to share management's enthusiasm for the deal and are responding accordingly.

Continue reading

Source Fool.com